NasdaqGS - Nasdaq Real Time Price USD
MacroGenics, Inc. (MGNX)
1.5400
-0.0100
(-0.65%)
At close: May 15 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 229,845 | 16 |
| Sales | 423 | 1 |
| Net Shares Purchased (Sold) | 229,422 | 17 |
| Total Insider Shares Held | 1.84M | -- |
| % Net Shares Purchased (Sold) | 14.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| RISSER ERIC BLASIUS Chief Operating Officer | -- | Direct | -- | Feb 14, 2025 |
| ECK STEPHEN L Officer | -- | Direct | -- | Feb 14, 2025 |
| SPITZNAGEL THOMAS Officer | -- | Direct | -- | Feb 14, 2025 |
| PETERS JEFFREY STUART General Counsel | -- | Direct | -- | Feb 14, 2025 |
| SMITH BETH ANN Officer and Treasurer | -- | Direct | -- | Feb 14, 2025 |
| KARRELS JAMES Chief Financial Officer | -- | Direct | -- | Feb 14, 2025 |
| KOENIG SCOTT Chief Executive Officer | -- | Direct | -- | Feb 14, 2025 |
| BONVINI EZIO Officer | -- | Direct | -- | Feb 14, 2025 |
| SMITH BETH ANN Officer and Treasurer | Sale at price 2.56 per share. | Direct | 1,083 | Feb 14, 2025 |
| RISSER ERIC BLASIUS Chief Operating Officer | -- | Direct | -- | Feb 7, 2025 |
| ECK STEPHEN L Officer | -- | Direct | -- | Feb 7, 2025 |
| SPITZNAGEL THOMAS Officer | -- | Direct | -- | Feb 7, 2025 |
| PETERS JEFFREY STUART General Counsel | -- | Direct | -- | Feb 7, 2025 |
| SMITH BETH ANN Officer and Treasurer | -- | Direct | -- | Feb 7, 2025 |
| KARRELS JAMES Chief Financial Officer | -- | Direct | -- | Feb 7, 2025 |
| KOENIG SCOTT Chief Executive Officer | -- | Direct | -- | Feb 7, 2025 |
| BONVINI EZIO Officer | -- | Direct | -- | Feb 7, 2025 |
| KOENIG SCOTT Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Oct 7, 2024 |
| KOENIG SCOTT Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Sep 23, 2024 |
| STUMP DAVID CARTER Director | -- | Direct | -- | May 20, 2024 |
| FERRANTE KAREN JEAN M.D. Director | -- | Direct | -- | May 20, 2024 |
| CHHABRA MEENU Director | -- | Direct | -- | May 20, 2024 |
| SIEGEL JAY PHILIP M.D. Director | -- | Direct | -- | May 20, 2024 |
| HURWITZ EDWARD Director | -- | Direct | -- | May 20, 2024 |
| O'BRIEN FEDERICA F Director | -- | Direct | -- | May 20, 2024 |
| HEIDEN WILLIAM K Director | -- | Direct | -- | May 20, 2024 |
| LIU MARGARET A Director | -- | Direct | -- | May 20, 2024 |
| JACKSON SCOTT THOMAS Director | -- | Direct | -- | May 20, 2024 |
| PETERS JEFFREY STUART General Counsel | Conversion of Exercise of derivative security at price 4.82 per share. | Direct | 204,850 | Apr 4, 2024 |
| PETERS JEFFREY STUART General Counsel | Sale at price 15.07 - 18.22 per share. | Direct | 799,148 | Apr 4, 2024 |
| PETERS JEFFREY STUART General Counsel | Conversion of Exercise of derivative security at price 10.15 - 11.50 per share. | Direct | 213,875 | Mar 6, 2024 |
| PETERS JEFFREY STUART General Counsel | Sale at price 21.50 per share. | Direct | 421,938 | Mar 6, 2024 |
| RISSER ERIC BLASIUS Chief Operating Officer | Conversion of Exercise of derivative security at price 10.15 per share. | Direct | 152,250 | Mar 4, 2024 |
| SPITZNAGEL THOMAS Officer | Conversion of Exercise of derivative security at price 11.50 per share. | Direct | 115,000 | Mar 4, 2024 |
| SPITZNAGEL THOMAS Officer | Sale at price 20.00 per share. | Direct | 200,000 | Mar 4, 2024 |
| KARRELS JAMES Chief Financial Officer | Sale at price 20.50 per share. | Direct | 615,000 | Mar 4, 2024 |
| RISSER ERIC BLASIUS Chief Operating Officer | Sale at price 19.63 - 20.00 per share. | Direct | 813,501 | Mar 4, 2024 |
| PETERS JEFFREY STUART General Counsel | Sale at price 17.22 per share. | Direct | 277,655 | Feb 26, 2024 |
| PETERS JEFFREY STUART General Counsel | -- | Direct | -- | Feb 22, 2024 |
| BONVINI EZIO Officer | -- | Direct | -- | Feb 22, 2024 |
| RISSER ERIC BLASIUS Chief Operating Officer | -- | Direct | -- | Feb 15, 2024 |
| ECK STEPHEN L Officer | -- | Direct | -- | Feb 15, 2024 |
| SPITZNAGEL THOMAS Officer | -- | Direct | -- | Feb 15, 2024 |
| PETERS JEFFREY STUART General Counsel | -- | Direct | -- | Feb 15, 2024 |
| KARRELS JAMES Chief Financial Officer | -- | Direct | -- | Feb 15, 2024 |
| KOENIG SCOTT Chief Executive Officer | -- | Direct | -- | Feb 15, 2024 |
| CILINSKI LYNN Officer and Treasurer | -- | Direct | -- | Feb 15, 2024 |
| BONVINI EZIO Officer | -- | Direct | -- | Feb 15, 2024 |
| BONVINI EZIO Officer | Sale at price 18.00 per share. | Direct | 60,012 | Feb 7, 2024 |
| PETERS JEFFREY STUART General Counsel | Conversion of Exercise of derivative security at price 10.15 - 11.50 per share. | Direct | 847,355 | Feb 5, 2024 |
Related Tickers
MRSN Mersana Therapeutics, Inc.
0.3145
-17.24%
KPTI Karyopharm Therapeutics Inc.
5.44
+12.16%
KALA KALA BIO, Inc.
3.2200
-1.53%
ASMB Assembly Biosciences, Inc.
12.50
+3.22%
FGEN FibroGen, Inc.
0.3020
+0.70%
GLYC GlycoMimetics, Inc.
0.2498
+4.52%
TNGX Tango Therapeutics, Inc.
1.5200
+18.29%
ALXO ALX Oncology Holdings Inc.
0.4358
-5.14%
ATRA Atara Biotherapeutics, Inc.
7.61
+15.13%
CHRS Coherus BioSciences, Inc.
0.7680
-2.80%